The healthtech startup is enhancing diagnostics for 6 million patients annually.

MEXICO CITY, MEXICO / ACCESSWIRE / July 17, 2024 / Eden, a company committed to democratizing health through cutting-edge technology, is proud to announce it has secured $10M in additional funding led by Sierra Ventures. Other investors include Kaszek, Alt Capital, Y-Combinator, and Khosla Ventures.

Founded by Julián Ríos and Raymundo González Leal, Eden aims to offer exceptional medical care and significantly improve the quality of life for populations in emerging economies and is already used by 75% of radiologists in Mexico.

"Eden's journey began with my mother's battle against breast cancer, exposing the shortcomings in our health system. Motivated by a desire to improve patient care, I gathered a team to create transformative healthcare technology. What started as a personal mission has now treated over 6 million patients, turning a dream into reality," said Julián Ríos, CEO and co-founder of Eden.

Eden's advanced AI technology processes vast amounts of medical data, allowing for quicker and more accurate diagnoses. This transformative approach is poised to revolutionize healthcare across Latin America and Central America, with the company aiming to become the region's leader in medical diagnostics within the next five years. Eden currently processes over 6 million studies annually, serving over 1,500 institutions across 17 countries.

Managing Partner at Sierra Ventures, Mark Fernandes, added, "Eden's innovative approach to medical diagnostics is set to transform the healthcare landscape in Latin America by delivering life-changing technology to millions of patients, starting with medical imaging. There is a lot of talk about AI in the medical industry, and Eden is one of the first companies implementing it at a massive scale."

Co-founder Julián Ríos envisions Eden as the company that will process the most medical diagnoses in Latin America. By verticalizing benefits within hospital systems and enabling radiologists to connect and verify diagnoses remotely, Eden is enhancing productivity, and efficiency, and reducing costs and turnaround times, ultimately benefiting the patient.

"Eden is not only advancing healthcare in LATAM but also challenging the global healthcare ecosystem. Investing in Eden is investing in a healthier future for hundreds of millions of patients," said investor Jack Altman.

Strategic alliances with prominent organizations such as Grupo Diagnóstico PROA, Laboratorios del Chopo, Grupo Santa María, Lapi Laboratorio, Imagenología Christus Muguerza, and the Health Secretariats of Chiapas and Chihuahua bolster Eden's credibility in the market. These partnerships testify to Eden's ability to deliver more accurate diagnoses and centralize patient care.

Eden's mission to democratize healthcare with advanced technology is transforming the medical landscape for millions of patients annually, bringing hope and improved outcomes to those in need.

About Eden

Eden is a healthcare technology company that uses AI to provide exceptional medical care and transform the quality of life for populations in emerging economies. Founded by Julián Ríos and Raymundo González Leal, Eden aims to lead the medical diagnostics field in Latin America and beyond. Learn more at https://edenmed.com/.

Media Contact:

Nina Pfister, MAG PR; E: nina@mooringadvisorygroup.com; T: 781-929-5620

SOURCE: Eden